Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Masimo smartwatches infringe Apple design patents, US jury says

By Blake Brittain

(Reuters) -Apple convinced a federal jury on Friday that health monitoring tech company Masimo (NASDAQ:MASI)’s smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple (NASDAQ:AAPL) that Masimo’s W1 and Freedom watches and chargers willfully violated Apple’s patent rights in smartwatch designs, awarding the tech giant $250 in damages. Apple’s attorneys told the court the “ultimate purpose” of its lawsuit was to win an injunction against sales of Masimo’s smartwatches after an infringement ruling.

The jury also determined that Masimo’s watches did not infringe Apple patents covering smartwatch inventions that the tech giant had accused Masimo of copying.

Masimo said in a statement that the company appreciated the jury’s verdict “in favor of Masimo and against Apple on nearly all issues,” and that the decision only applied to a “discontinued module and charger.”

“Apple primarily sought an injunction against Masimo’s current products, and the jury’s verdict is a victory for Masimo on that issue,” Masimo said.

Apple said in a statement that it was “glad the jury’s decision today will protect the innovations we advance on behalf of our customers.”

Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S. International Trade Commission last year to block imports of Apple’s Series 9 and Ultra 2 smartwatches after the commission found that their technology for reading blood oxygen levels infringed Masimo’s patents.

Apple has appealed the decision and resumed selling the watches after removing the technology. The tech giant countersued Masimo for patent infringement in 2022, alleging that Masimo copied Apple Watch features to use in its smartwatches.

Apple also accused Masimo of using lawsuits at the ITC and in California to “make way for Masimo’s own watch.” Masimo said Apple’s patent lawsuit was “retaliatory” and “an attempt to avoid the court in which the parties have been litigating their dispute.”

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com